开发和评估一种创新的炎症预后评分,用于预测肺栓塞患者的长期死亡率
Ning Zhu1,2, Lei Zhang3, Jiabao Wu1
1Department of Respiratory and Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, China, fjmu.edu.cn.
Mediators of inflammation
|January 7, 2026
概括
一个新的炎症预后得分 (IPS) 有效地预测肺栓塞 (PE) 患者的长期死亡率. 这个得分,使用五个常见的生物标志物,改善风险分层超越传统的临床因素.
科学领域:
- 生物标志物和炎症研究研究
- 心血管医学 心血管医学
- 肺部医学 肺部医学
背景情况:
- 系统性炎症是肺栓塞 (PE) 中不良结果的已知危险因素.
- 预测急性PE患者的长期死亡率对于有效管理至关重要.
- 现有的预后工具可能无法完全捕捉炎症标志物的影响.
研究的目的:
- 开发和验证一种新的炎症预后评分 (IPS).
- 评估IPS对急性PE患者长期全因死亡率的预测价值.
- 为了确定IPS是否在与临床预测因素相结合时增强风险分层.
主要方法:
- 对1642名急性PE患者进行了回顾性队列研究.
- 对15种炎症生物标志物的分析,包括C反应蛋白 (CRP),白细胞计数 (WBC) 和像系统性免疫炎症指数 (SII) 这样的衍生指数.
- 使用LASSO考克斯回归构建IPS,通过生存分析,考克斯回归,ROC分析和随机生存森林 (RSF) 评估预后性能.
主要成果:
- 在43.87个月的中位数随访期间,16.0%的患者死亡.
- 开发的IPS (0.395×IBI + 0.236×RDW + 0.208×SIRI + 0.115×MLR + 0.040×CRP) 与死亡率有显著的相关性 (aHR=2.55).
- 当IPS被添加到临床模型中时,它将3年AUC从0.820提高到0.886,显示出优越的风险分层.
结论:
- 由五种易于获得的炎症生物标志物衍生出的IPS是急性PE中长期死亡率的独立预测指标.
- IPS显著提高了风险分层,超出了传统的临床因素.
- 这一分数为早期预后评估和PE患者个性化治疗策略提供了潜力.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
308
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
308
Pulmonary Embolism III: Nursing Management
351
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
351
Pulmonary Embolism I: Introduction
500
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
500


